Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
--- How Cypris Can Support GLP-1 and Obesity Drug Innovation Intelligence For R&D and innovation teams tracking the rapidly evolving GLP-1 and obesity therapeutics landscape, maintaining comprehensive awareness across patents, scientific literature, clinical trials, and competitive intelligence presents significant challenges
Author Use of AI Tools Statement During the preparation of this manuscript, the authors used Microsoft Co-Pilot for the purpose of improving clarity and grammar
Richardson M
Planned breaks differ from arbitrary stopping, which often leads to rapid regain
With GLP-1 medications: You pharmacologically reduce the dopamine-seeking behavior the food noise quiets but because the same pathways handle all reward and motivation non-food joys can get quieter too
US$ 27.01
US$ 21.49
US$ 27.88
US$ 24.00
/assets/images/provider/photos/2636390.jpg)
/assets/images/provider/photos/2737000.jpeg)
